Platelet rich plasma effectiveness in bowel anastomoses: A systematic review

doi:10.4240/wjgs.v13.i12.1736

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3558)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

245

WORD

106

HTML

1910

Figures (1-2)

235

Tables (1-3)

245

Sum=2741

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

315

Download

502

Sum=817

Dec 27, 2021 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastrointest Surg. Dec 27, 2021; 13(12): 1736-1753
Published online Dec 27, 2021. doi: 10.4240/wjgs.v13.i12.1736

Table 3 Verhofstad histopathology scale

Groups	Necrosis	Neutrophil	Lymphocyte	Macrophages	Oedema	Mucosal epithelium	Submucosal layer	Bridging	Total
Ocak et al[34]
Control	2.3 ± 0.82	2.5 ± 0.52	2.5 ± 0.52	2.5 ± 0.52	2.9 ± 0.31	2.6 ± 0.966	0.8 ± 0.63	-	-
PRP	2.6 ± 0.69	2.8 ± 0.42^a	2.7 ± 0.48^a	2.7 ± 0.48^a	2.9 ± 0.31	2.6 ± 0.516	1.4 ± 0.69	-	-
Fibrin glue	2 ± 0.66	2.1 ± 0.31^a	2.1 ± 0.31^a	2.1 ± 0.31^a	2 ± 0.47	2.6 ± 0.516	1.3 ± 0.67	-	-
Buk et al[35]
Control	2.3 ± 0.82	1.9 ± 0.56^a	1.8 ± 0.42^a	2 ± 0.47	2.1 ± 0.56^a	2.6 ± 0.966	0.8 ± 0.63^a	-	-
Oxaliplatin	2.5 ± 0.52	2.9 ± 0.52^a	2.4 ± 0.51^a	2.5 ± 0.52	2.8 ± 0.42^a	2.6 ± 0.516	2 ± 0.94^a	-	-
Oxaliplatin + PRP	2.7 ± 0.58	2 ± 0.47^a	1.8 ± 0.42^a	2.3 ± 0.67	2.1 ± 0.56^a	2.5 ± 0.54	1.6 ± 0.96^a	-	-
Aydin et al[17]
Control	1 ± 1	2 ± 1	-	2 ± 0	2 ± 1	3 ± 1	3 ± 0	-	-
L-PRP	0 ± 2	2 ± 1	-	2 ± 0	1 ± 0^a	2.5 ± 1^a	3 ± 2	-	-
H-PRP	1.5 ± 2	2 ± 2	-	2 ± 1	0 ± 0^a	1 ± 2^a	3 ± 0	-	-
Göksu et al[30]
Control	2.38 ± 0.51	2.38 ± 0.518	2.38 ± 0.51^a	-	2.75 ± 0.46^a	2.63 ± 0.51	1.75 ± 0.46	-	-
5-FU	2.63 ± 0.51	2.50 ± 0.463	2.63 ± 0.51^a	-	2.75 ± 0.46^a	2.50 ± 0.53	1.25 ± 0.46	-	-
5-FU + PRP	2.13 ± 0.35	2.13 ± 0.518	2 ± 1^a	-	2 ± 0.53^a	2.63 ± 0.51	1.25 ± 0.46	-	-
Sozutek et al[31]
Control	0.3 ± 0.48	1.3 ± 0.94	1 ± 0.47	1 ± 0^a	0.4 ± 0.51	0.3 ± 0.48	-	0.6 ± 0.51	4.9 ± 1.28
Control + PRP	0.2 ± 0.42	0.7 ± 0.67	1 ± 0.47	1.6 ± 0.51^a	0.3 ± 0.48	0.4 ± 0.48	-	0.2 ± 0.42	4.3 ± 1.33
Septic	1.1 ± 0.64	1.5 ± 0.53	1.6 ± 0.51^a	1.1 ± 0.83	1.2 ± 0.71^a	1 ± 0.53	-	1.2 ± 0.71	9.8 ± 1.12^a
Septic + PRP	0.7± 0.48	1.2 ± 0.42	1.3 ± 0.48^a	1.5 ± 0.52	0.4 ± 0.51^a	0.5 ± 0.51	-	0.8 ± 0.42	6.1 ± 1.37^a
Gorur et al[32]
Control	0.3 ± 0.67^a	1.3 ± 0.9	1 ± 0.47	1 ± 0	1.1 ± 0.31^a	0.3 ± 0.57^a	-	1.2 ± 0.78^a	-
5-FU	1 ± 1.05^a	1.5 ± 0.53	1.4 ± 0.32	1.1 ± 0.83	2 ± 0.73^a	1.1 ± 0.42^a	-	1.5 ± 0.52^a	-
Control + PRP	0^a	0.7 ± 0.67	1 ± 0.67	1.8 ± 0.31	1 ± 0.47^a	0.3 ± 0.57^a	-	0.9 ± 0.87^a	-
5-FU + PRP	0.1 ± 0.3	1.2 ± 0.42	1.5 ± 0.58	1.6 ± 0.53	1.7 ± 0.48	0.6 ± 0.57	-	1.1 ± 0.31	-

^aP < 0.05, represents a statistically significant difference between values.

5-FU: 5-Fluorouracil; PRP: Platelet rich plasma.

Citation: Geropoulos G, Psarras K, Giannis D, Martzivanou EC, Papaioannou M, Kakos CD, Pavlidis ET, Symeonidis N, Koliakos G, Pavlidis TE. Platelet rich plasma effectiveness in bowel anastomoses: A systematic review. World J Gastrointest Surg 2021; 13(12): 1736-1753
URL: https://www.wjgnet.com/1948-9366/full/v13/i12/1736.htm
DOI: https://dx.doi.org/10.4240/wjgs.v13.i12.1736